"non-device and non-procedure related deaths" - sell off was ridiculous to start with, Initial rollout of C-Pulse was slow and perhaps the patients they took on had other comorbidities. Expect more non related deaths depending on who they enrolled.
SHC Price at posting:
2.5¢ Sentiment: Hold Disclosure: Held
